
Enable job alerts via email!
A leading academic institution in Manchester seeks a researcher to join their Molecular Cell Biology team. This role involves investigating retinal pigment epithelium biology in the context of ageing and disease using innovative cell-based models. Candidates should hold a PhD in molecular/cell biology with experience in disease models, cell culture, and data analysis. This position offers opportunities for collaborative research and high-quality publications.
This is an exciting opportunity to join the Molecular Cell Biology and Mechanisms of Disease Group led by Professor Luminita Paraoan, in the Department of Life Sciences at Manchester Metropolitan University. The project focuses on the biology and function of the retinal pigment epithelium (RPE) in health, ageing and disease. It aims to use innovative, advanced in vitro cell-based models to characterise the role of ageing through genetic and pharmacological interventions and to deploy CRISPR screens to interrogate pathways involved in crosstalk between IRD pathogenesis and ageing.
The experimental research will be carried out in fully equipped, modern laboratories with state-of-the-art facilities in the Dalton Building in central Manchester, with opportunities to engage with established national and international collaborations of the group.
Inherited retinal dystrophies (IRDs) are a heterogeneous group of degenerative disorders, mostly monogenic, impacting retinal structure and function. They are designated as orphan or rare diseases, affecting a limited portion of the population, such that specific patient cohorts and the body of research and treatment options are limited. Later-onset IRDs tend to be progressive and worsen with age. The biological and clinical implications of ageing on IRD progression, epidemiology, severity, and the molecular mechanisms underpinning pathology have yet to be investigated. With an ageing population and late diagnoses, studying this interaction is significant for developing novel, gene-agnostic therapeutic approaches.
The current project aims to deploy high-throughput CRISPR-Cas9 genomic screening to identify molecular processes at the interface of IRDs and ageing that can be leveraged for gene-agnostic therapies.
To be successful in this role, you will:
The post holder will be expected to:
We believe in working together, sharing knowledge and valuing everyone's contributions. Develop your skills, further your knowledge and be part of a team transforming lives every day.
Manchester Metropolitan University fosters an inclusive culture of belonging that promotes equity and celebrates diversity. We value a diverse workforce and welcome applications from local and international communities, including those from Black, Asian, and Minority Ethnic backgrounds, disabled people, and LGBTQ+ individuals.
We support flexible working arrangements, including hybrid and tailored schedules, which can be discussed with your line manager. If you require reasonable adjustments during recruitment or in your role, please let us know so we can provide appropriate support. Our commitment to inclusivity includes mentoring programmes, accessibility resources and professional development opportunities to empower and support underrepresented groups.
Find out more about our story and explore our campus.